Acute lung injury (ALI) is characterized by alveolar-capillary barrier disruption, increased pulmonary permeability, impaired gas exchange, and inflammation. Lipopolysaccharide (LPS), a potent microbial trigger of inflammation, is widely used to model ALI. Short palate, lung, and nasal epithelial clone 1 (SPLUNC1), als...
The synthetic AMP A4S7 was investigated, which effectively inhibited DENV-2 RNA and protein expression and reduced viral progeny production at specified concentrations without exhibiting cytotoxicity in Vero cells, and found the α-helical structure of A4S7 was found to be crucial for its antiviral activity.
Ting-Chun Lin, Jeng-Wei Lu, Chia-Hsin Liu et al.· Antiviral Research· 0 citations
Respiratory infections remain a major global health burden despite advances in systemic antimicrobial therapy. Antimicrobial dry powder inhalers (DPIs) have emerged as precision-engineered pulmonary delivery platforms capable of achieving high local drug concentrations while minimizing systemic toxicity. This review ex...
Hasham Shafi, David Encinas-Basurto, Y. Di et al.· Lung· 0 citations
Anticancer peptides (ACPs) are frequently discussed as a single therapeutic class, yet the term encompasses molecules that perform markedly different jobs: direct tumor-cell killing, intracellular target modulation, tumor homing and penetration, or selective delivery of a separate payload. This functional diversity cre...
The first mechanistic insights into the interaction of Esc(1–21) with CFTR in a cellular context are provided and the NBD1-NBD2 interface is identified as a suitable target for peptide-based potentiators to support the development of Esc(1–21) and its derivatives as novel multifunctional therapeutic candidates for CF t...
D. Baroni, L. Ferrera, Mario Passalacqua et al.· ACS Omega· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.